An NCI-designated Comprehensive Cancer Center
Lee-Stephen

Stephen J. Lee, M.D.

Gynecologic Oncology Surgeon
Clinical Expertise
Appointments
Assistant Clinical Professor, Division of Gynecologic Oncology, Department of Surgery
Contact
South Pasadena Patients: 877-998-7546
Referring Physicians/Colleagues: 626-218-0330
Email: [email protected]
Other Languages Spoken
  • Korean
  • Spanish

Clinical Teams

Stephen J. Lee, M.D., is a gynecologic oncologist specializing in advanced cytoreductive procedures for ovarian cancer, which can significantly improve the survival outcome for patients. He is also an expert in robotic-assisted (minimally invasive) surgery for uterine and cervical cancers, which can reduce scarring, pain and recovery time.

Dr. Lee received his medical doctorate from the Feinberg School of Medicine of Northwestern University in Chicago and completed an internship in general surgery at Rush University Medical Center, also in Chicago. He continued his postgraduate training at the Albert Einstein College of Medicine in Bronx, New York, in obstetrics and gynecology, and completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center. He has written more than 20 publications and has been invited to discuss his work nationally and internationally.

Locations

City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

City of Hope South Pasadena, 209 Fair Oaks Ave.

South Pasadena, CA 91030

Suidan RS, St Clair CM, Lee SJ, Barlin JN, Long Roche KC, Tanner EJ, Sonoda Y, Barakat RR, Zivanovic O,Chi DS. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecol Oncol. 2014 Sep;134(3):468-72

Lee SJ, Calderon B, Gardner GJ, Mays A, Nolan S, Sonoda Y, Barakat RR, Leitao MM Jr. The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications. Gynecol Oncol. 2014 Jun;133(3):552-5

Leitao MM Jr, Bartashnik A, Wagner I, Lee SJ, Caroline A, Hoskins WJ, Thaler HT, Abu-Rustum NR, Sonoda Y, Brown CL, Jewell EL, Barakat RR, Gardner GJ. Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers. Obstet Gynecol. 2014 May;123(5):1031-7

Seagle BL, Falter KJ 2nd, Lee SJ, Frimer M, Samuelson R, Shahabi S. Mullerian adenosarcoma of the cervix: report of two large tumors with sarcomatous overgrowth or heterologous elements. Gynecol Oncol Case Rep. 2014 May 5;9:7-10

Sandadi S, Gadzinski JA, Lee S, Chi DS, Sonoda Y, Jewell EL, Brown CL, Gardner GJ, Barakat RR, Leitao MM Jr. Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy. Gynecol Oncol. 2014 Jan;132(1):102-6

Sandadi S, Lee S, Walter A, Gardner GJ, Abu-Rustum NR, Sonoda Y, Brown CL, Jewell E, Parameswaran R, Barakat RR, Leitao MM Jr. Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstet Gynecol. 2012 Nov;120(5):1077-83

Einstein MH, Klobocista M, Hou JY, Lee S, Mutyala S, Mehta K, Reimers LL, Kuo DYS, Huang GS, Goldberg GL. Phase II Trial of Adjuvant Pelvic Radiation "Sandwiched" Between Ifosfamide or Ifosfamide plus Cisplatin in Women with Uterine Carcinosarcoma. Gynecol Oncol. 2012 Jan;124(1):26-30

Gupta D, Gunter MJ, Yang K, Lee S, Zuckerwise L, Chen L, Goldberg GL, Huang GS: Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma. International Journal ofGynecological Cancer. 2011;21(3):529-534

In The News